|
|
|
|
||
Re: Vascepa Rx per tucaman on iHub (ATH The 8% change is week-over-week, not year-over-year. Digging out the comparable week from 2019, the year-over-year growth is: Vascepa TRx +49.8% NRx +34.0%
Scripts for week ending 10/23/2020 Below the updated script numbers. I included scripts for Lovaza (incl. Generic, though not sure I captured all suppliers) - for reference. I'll leave it to RAF and Sam to comment on plausibility of the figures. Vascepa TRx: 98'344 (+8.14%) NRx: 46'103 (+9.61%) Generic Lovaza TRx: 65'667 (+4.93%) NRx: 34'583 (+8.64%)
NORMALIZED Scripts Update for Week Ending 25/10 ATH Across the Board in Numbers & Market Share V TRx: 73,930 {vs 71,927; +2.79%} NRx: 34,405 {vs 32,917; +4.52%} |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
7758 | Re: Vascepa Rx per tucaman on iHub (ATH | ex_hacker202 | 1 | 10/31/2020 1:04:58 PM |